MINNEAPOLIS (WCCO)-- Mayo Clinic is releasing pre-published data that it says confirms the critical role masks play in preventing COVID-19 infection. On Tuesday, the Mayo Clinic said it is releasing ...

ROCHESTER — A recently published Mayo Clinic study evaluates how caring for a child, spouse or aging parent affects menopause symptoms. "The average age of menopause in our country is 51 to 52 years," ...

Rochester, Md.-based Mayo Clinic has announced a partnership with leading pharmaceutical manufacturer Baxter and the biotech arm of Velocity Pharmaceutical Development, a bioscience development firm ...

Sep. 15—ROCHESTER — A new study from Mayo Clinic researchers investigates the causes of heart attacks in people younger than age 65. "Understanding why a heart attack happened is just as important as ...

ROCHESTER — Marissa Schafer is an observer, by nature and by trade. As a child, she found herself fascinated by the human body, how it works and what happens when it malfunctions. "As I learned more ...

The platform will provide secure, decentralized data capture, document management, study monitoring and electronic consent for the clinical trial, according to the tech company's announcement. Mayo ...

InSitu Biologics is a biotech company focused on the development of a multi-phase prolonged release drug delivery platform for localized treatment of pain, cancer, and infection. Among its products is ...

The Nature Index tracks primary research articles from 145 natural-science and health-science journals, chosen based on reputation by an independent group of researchers. The Nature Index provides ...

Covid-19 created a shift in the delivery of clinical trials, allowing for participants to access trials outside of a traditional research site, thus expanding the scope of clinical trials. That was ...

Mayo Clinic will go out-of-network next year for most Medicare Advantage plans from two of the nation's largest health insurers. The changes, which UnitedHealthcare and Humana confirmed over the past ...

A Mayo Clinic-led team of researchers is solving one of the most frustrating aspects of genetic cancer screening — results that give zero guidance to patients on whether they are at elevated risk.